Optogenetic Characterization and Control of Stem Cell Signaling

产品说明：拟议工作的目标是利用光遗传学来研究成人神经干细胞（NSC）和胚胎干细胞（ESC）中的关键信号通路- Wnt和Rho。干细胞因其组织再生的潜力而被广泛探索，包括操纵驻留在患者组织内的内源性干细胞的策略（例如，成体神经干细胞）以及植入外源培养的干细胞（例如，胚胎或诱导的多能干细胞）或它们的分化后代。然而，控制干细胞自我更新和分化的信号传导机制的基本知识目前还不完整，这限制了我们对它们在成人功能中的作用的理解，并使精确控制干细胞行为用于再生医学应用的努力变得复杂。光是研究细胞功能的有力工具。特别是，在空间和时间上调节Wnt和Rho信号通路的能力将使我们能够阐明它们在控制干细胞命运中的作用，这对于生物医学应用至关重要。为此，我们最近开发了光遗传学方法，该方法能够通过组装纳米级信号复合物将光输入引导到几个确定的信号通路中。具体而言，我们设计了经典Wnt信号通路以及RhoA通路的光活化激动剂。我们也有能力使用显微镜技术进行单分子荧光成像在纳米级的分辨率和使用生物传感器的荧光共振能量转移（FRET）的基础上表征Rho GTdR活性活细胞中的真实的时间。这项工作的第一个目的是确定神经干细胞和胚胎干细胞中Wnt/β-连环蛋白信号的光遗传学激活是否可以阐明干细胞调控的机制。第二个目的是使用光遗传学来探测NSC中的Rho GT3信号传导和串扰。第三个目的是确定Cry 2是否可以被工程化用于细胞表面受体活化和用于细胞信号传导的多重刺激。我们预计，应用我们的新型光遗传学方法将阐明Wnt和Rho通路在调节神经干细胞和胚胎干细胞的细胞命运选择中的动态作用。此外，我们将开发的新型光遗传学方法将进一步加强未来对细胞和干细胞生物学中关键信号通路的研究。由此产生的对干细胞生物学和工程学的机械见解将极大地影响基于细胞替代和再生医学的恢复器官功能的方法。

DESCRIPTION: The objective of the proposed work is to use optogenetics to investigate key signaling pathways - Wnt and Rho - in adult neural stem cells (NSCs) and embryonic stem cells (ESCs). Stem cells are being broadly explored for their potential for tissue regeneration, including strategies to manipulate endogenous stem cells residing within a patient's tissues (e.g., adult neural stem cells) as well as to implant exogenously cultured stem cells (e.g., embryonic or induced pluripotent stem cells) or their differentiated progeny. However, basic knowledge of the signaling mechanisms that control stem cell self-renewal and differentiation is currently incomplete, which limits our understanding of their role in adult function and complicates efforts to precisely control stem cell behavior for regenerative medicine applications. Light is a powerful tool to investigate cellular function. In particular, the abilityto modulate the Wnt and Rho signaling pathways spatially and temporally would allow us to elucidate their role in controlling stem cell fate, which is critical for biomedical applications. o this end, we recently developed optogenetic methods that enable a light input to be channeled into several defined signaling pathways through the assembly of nanoscale signaling complexes. Specifically, we engineered a photo-activatable agonist of the canonical Wnt signaling pathway as well as the RhoA pathway. We also have the ability to use microscopy techniques to conduct single molecule fluorescent imaging at nanoscale resolutions and to use biosensors based on fluorescence resonance energy transfer (FRET) to characterize Rho GTPase activities in live cells in real time. The first aim of the proposed work is to determine whether optogenetic activation of Wnt/¿-catenin signaling in NSCs and ESCs can elucidate mechanisms of stem cell regulation. The second aim is to use optogenetics to probe Rho GTPase signaling and crosstalk in NSCs. The third aim is to determine whether Cry2 can be engineered for cell surface receptor activation and for multiplexed stimulation of cellular signaling. We anticipate that applying our novel optogenetic approaches will elucidate the dynamic roles of the Wnt and Rho pathways in regulating cell fate choices in NSCs and ESCs. Moreover, the novel optogenetic methods that we will develop will further enhance future investigations of key signaling pathways in cell and stem cell biology. The resulting mechanistic insights into stem cell biology and engineering will greatly impact approaches to restore organ function based on cell replacement and regenerative medicine.